Physician profile
Deirdre Warde
NPI 1891009528
$2,052.79
in general payments reported to CMS, 2019-2025
22 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2020: $190 · 2021: $63.07 · 2022: $176 · 2023: $295 · 2024: $249 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $562.75 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $239.92 | 2019-2022 | |
| Lilly USA, LLC | $190.78 | 2019-2025 | Mounjaro, Zepbound |
| Daiichi Sankyo INC. | $183.97 | 2019-2025 | Injectafer |
| Genentech USA, INC. | $124.81 | 2019 | |
| Heartflow, INC. | $110.70 | 2022-2024 | Ffrct |
| Exact Sciences Corporation | $76.67 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.50 | 2023 | Lifevest |
| Merck Sharp & Dohme LLC | $61.25 | 2020-2024 | Gardasil 9, Gardasil, Capvaxive |
| Amgen INC. | $58.10 | 2023-2025 | Otezla, Repatha, Repatha |
| Glaxosmithkline, LLC. | $50.11 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $41.97 | 2019-2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.60 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $37.88 | 2024 | Voquezna |
| Pfizer INC. | $35.28 | 2022-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $34.88 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $34.87 | 2019-2020 | |
| Amarin Pharma, INC. | $33.61 | 2020-2021 | |
| Tactile Systems Technology INC | $22.32 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.11 | 2019 | |
| Circassia INC. | $16.20 | 2019 | |
| Cipher Pharmaceuticals US LLC | $15.51 | 2025 | Natroba, Spinosad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deirdre Warde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.